You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Desloratadine And Pseudoephedrine Sulfate 24 Hour patents expire, and what generic alternatives are available?

Desloratadine And Pseudoephedrine Sulfate 24 Hour is a drug marketed by Dr Reddys Labs Ltd and is included in one NDA.

The generic ingredient in DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR is desloratadine; pseudoephedrine sulfate. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the desloratadine; pseudoephedrine sulfate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR?
  • What are the global sales for DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR?
  • What is Average Wholesale Price for DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR?
Summary for DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR
Drug patent expirations by year for DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR
Recent Clinical Trials for DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Dr. Reddy's Laboratories LimitedPhase 1

See all DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR clinical trials

US Patents and Regulatory Information for DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR desloratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 078366-001 Apr 26, 2011 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.